Patents by Inventor Shumin Yang
Shumin Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240241603Abstract: Provided is a method of preventing false triggering, which is applied to a wearable device, including: if it is detected that a touch structure is triggered, obtaining pressure values acquired by the at least two pressure sensors, wherein the touch structure and the at least two pressure sensors are disposed on a side wall of a housing of the wearable device, and distances between each of the at least two pressure sensors and the touch structure are different; determining whether all the pressure values acquired by the pressure sensors are in a predetermined reference pressure range. If all the pressure values acquired by the pressure sensors are in the predetermined reference pressure range, respond to an event that the touch structure is triggered, and if not all the pressure values acquired by the pressure sensors are in the predetermined reference pressure range, determine that the touch is false triggering.Type: ApplicationFiled: October 25, 2021Publication date: July 18, 2024Inventors: Zongxu YANG, Shupeng LI, Guiming CAO, Tao SUI, Shumin TAN
-
Patent number: 12040332Abstract: An array substrate and a display panel are provided. The array substrate includes a substrate, a common electrode line, a data line, a pixel electrode, and a shielding line. The common electrode line is disposed on the substrate. The data line is disposed on the common electrode line. The pixel electrode is disposed on the data line. The shielding line is disposed on the data line and includes a first shielding line and a second shielding line connected. The first shielding line and the pixel electrode are disposed in a same layer, and the second shielding line is disposed between the first shielding line and the data line. An orthographic projection of the first shielding line and the second shielding line on the substrate covers an orthographic projection of the data line on the substrate.Type: GrantFiled: June 9, 2023Date of Patent: July 16, 2024Assignee: TCL CHINA STAR OPTOELECTRONICS TECHNOLOGY CO., LTD.Inventors: Lei Huang, Liu Yang, Shumin Tang
-
Publication number: 20210397081Abstract: A method for manufacturing grating reference materials having a self-traceability includes: acquiring a mask substrate including a window region and a non-window region; fabricating, a self-traceability mask on the mask substrate by using a laser-focused atomic deposition technique; acquiring a photoresist sample including an extreme ultraviolet photoresist and a second substrate; exposing the extreme ultraviolet photoresist by combining the self-traceability mask with the soft x-ray interference lithography, and then performing a development process after exposing to obtain a photoresist grating structure; and transferring the photoresist grating structure to the second substrate to obtain the grating reference materials.Type: ApplicationFiled: May 26, 2021Publication date: December 23, 2021Inventors: Xinbin CHENG, Xiao DENG, Jun ZHAO, Shumin YANG, Chaofan XUE, Yanqing WU, Renzhong TAI, Jie LIU, Zhenjie GU, Tongbao LI
-
Publication number: 20090111970Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: ApplicationFiled: September 19, 2008Publication date: April 30, 2009Inventors: Shumin Yang, Catherine A. McCall, Eric R. Weber
-
Patent number: 7427661Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: GrantFiled: November 20, 2006Date of Patent: September 23, 2008Assignee: Heska CorporationInventors: Shumin Yang, Catherine A. McCall, Eric R. Weber
-
Patent number: 7385045Abstract: The present invention relates to B7 proteins; to B7 nucleic acid molecules, including those that encode such B7 proteins; to antibodies raised against such B7 proteins; and to therapeutic compounds that regulate B7 function. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: GrantFiled: November 28, 2005Date of Patent: June 10, 2008Assignee: Heska CorporationInventors: Shumin Yang, Gek-Kee Sim
-
Publication number: 20070141671Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: ApplicationFiled: November 20, 2006Publication date: June 21, 2007Inventors: Shumin Yang, Catherine McCall, Eric Weber
-
Patent number: 7183080Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: GrantFiled: February 24, 2004Date of Patent: February 27, 2007Assignee: Heska CorporationInventors: Shumin Yang, Catherine A. McCall, Eric R. Weber
-
Publication number: 20060216786Abstract: The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds.Type: ApplicationFiled: March 6, 2006Publication date: September 28, 2006Inventors: Gek-Kee Sim, Shumin Yang, Matthew Dreitz, Ramani Wonderling
-
Publication number: 20060199947Abstract: The present invention relates to B7 proteins; to B7 nucleic acid molecules, including those that encode such B7 proteins; to antibodies raised against such B7 proteins; and to therapeutic compounds that regulate B7 function. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: ApplicationFiled: November 28, 2005Publication date: September 7, 2006Inventors: Shumin Yang, Gek-Kee Sim
-
Patent number: 7078506Abstract: The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds.Type: GrantFiled: August 13, 2002Date of Patent: July 18, 2006Assignee: Heska CorporationInventors: Gek-Kee Sim, Shumin Yang, Matthew J. Dreitz, Ramani S. Wonderling
-
Patent number: 7053181Abstract: The present invention relates to B7 proteins; to B7 nucleic acid molecules, including those that encode such B7 proteins; to antibodies raised against such B7 proteins; and to therapeutic compounds that regulate B7 function. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: GrantFiled: March 1, 2004Date of Patent: May 30, 2006Assignee: Heska CorporationInventors: Shumin Yang, Gek-Kee Sim
-
Patent number: 7026139Abstract: The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds.Type: GrantFiled: September 30, 2002Date of Patent: April 11, 2006Assignee: Heska CorporationInventor: Shumin Yang
-
Patent number: 6852847Abstract: The present invention relates to canine and feline B7 proteins; to B7 nucleic acid molecules, including those that encode such B7 proteins; to antibodies raised against such B7 proteins; and to therapeutic compounds that regulate B7 function. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: GrantFiled: March 19, 1999Date of Patent: February 8, 2005Assignee: Heska CorporationInventors: Gek-Kee Sim, Shumin Yang, Karen S. Sellins
-
Publication number: 20040191868Abstract: The present invention relates to canine interleukin-5 proteins; canine interleukin-5 nucleic acid molecules, including those that encode canine interleukin-5 proteins; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: ApplicationFiled: February 24, 2004Publication date: September 30, 2004Applicant: Heska CorporationInventors: Shumin Yang, Catherine A. McCall, Eric R. Weber
-
Publication number: 20040157296Abstract: The present invention relates to B7 proteins; to B7 nucleic acid molecules, including those that encode such B7 proteins; to antibodies raised against such B7 proteins; and to therapeutic compounds that regulate B7 function. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.Type: ApplicationFiled: March 1, 2004Publication date: August 12, 2004Inventors: Shumin Yang, Gek-Kee Sim
-
Publication number: 20030143196Abstract: The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds.Type: ApplicationFiled: September 30, 2002Publication date: July 31, 2003Inventors: Gek-Kee Sim, Shumin Yang, Matthew J. Dreitz, Ramani S. Wonderling
-
Publication number: 20030099609Abstract: The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds.Type: ApplicationFiled: August 13, 2002Publication date: May 29, 2003Inventors: Gek-Kee Sim, Shumin Yang, Matthew J. Dreitz, Ramani S. Wonderling
-
Patent number: 6482403Abstract: The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds.Type: GrantFiled: December 1, 1999Date of Patent: November 19, 2002Assignee: Heska CorporationInventors: Gek-Kee Sim, Shumin Yang, Matthew J. Dreitz, Ramani S. Wonderling
-
Patent number: RE40374Abstract: The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds.Type: GrantFiled: August 13, 2004Date of Patent: June 10, 2008Assignee: Heska CorporationInventor: Shumin Yang